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Abstract
In low- and middle-income countries (LMIC) in Asia, pharmacies are often patients’ first point of con-
tact with the health care system and their preferred channel for purchasing medicines. Unfortunately,
pharmacy practice in these settings has been characterized by deficient knowledge and inappropriate
treatment. This paper systematically reviews both the performance of all types of pharmacies and
drug stores across Asia’s LMIC, and the determinants of poor practice, in order to reflect on how this
could best be addressed. Poor pharmacy practice in Asia appears to have persisted over the past 30
years. We identify a set of inadequacies that occur at key moments throughout the pharmacy encoun-
ter, including: insufficient history taking; lack of referral of patients who require medical attention; il-
legal sale of a wide range of prescription only medicines without a prescription; sale of medicines that
are either clinically inappropriate and/or in doses that are outside of the therapeutic range; sale of in-
complete courses of antibiotics; and limited provision of information and counselling. In terms of de-
terminants of poor practice, first knowledge was found to be necessary but not sufficient to ensure cor-
rect management of patients presenting at the pharmacy. This is evidenced by large discrepancies
between stated and actual practice; little difference in the treatment behaviour of less and more quali-
fied personnel and the failure of training programmes to improve practice to a satisfactory level.
Second, we identified a number of profit maximizing strategies employed by pharmacy staff that can
be linked to poor practices. Finally, whilst the research is relatively sparse, the regulatory environment
appears to play an important role in shaping behaviour. Future efforts to improve the situation may
yield more success than historical attempts, which have tended to concentrate on education, if they ad-
dress the profit incentives faced by pharmacy personnel and the regulatory system.
Key words: Asia, developing countries, pharmacies, private sector, quality of care
Key Messages
• Pharmacy practice in Asia is characterised by insufficient history taking; a lack of appropriate patient referral; poor ad-
herence to treatment guidelines, inappropriate supply of medicines and insufficient counselling.
• Adequate knowledge alone is not sufficient to ensure appropriate management of patients presenting at the pharmacy.
Profit incentives and the regulatory environment must be taken into consideration when designing interventions to im-
prove pharmacy practice in these settings.
• Intervention research in this area appears to be lacking and more research is particularly required on non pharmacist-
run pharmacies and unregistered drug shops.
VC The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Introduction
The role of the private sector in the provision of medicines has trad-
itionally been neglected by governments and the international public
health community alike (Bigdeli et al. 2014). Yet in most low-and
middle-income countries (LMIC) it is widely established that private
pharmacies and drug stores are typically patients’ first point of con-
tact with the healthcare system and the preferred channel through
which to purchase medicines (Smith 2009b). For example, in Asia,
pharmacies have been found to be the dominant source of healthcare
for all common problems amongst poor populations in Bangladesh
(Khan et al. 2012) and in Western Nepal, amongst mothers seeking
care for their children, pharmacies were the most popular source
(46.2%) (Sreeramareddy et al. 2006). Their appeal lies in long open-
ing hours, availability of medicines (including the possibility of
credit and the option to purchase medicines in small quantities), geo-
graphic accessibility and personal familiarity (Van Der Geest 1982;
Logan 1983; Kloos et al. 1986, Greenhalgh 1987; Igun 1987; Haak
1988; Price 1989; Mayhew et al. 2001). Further, many patients have
neither the time nor money to consult a physician (Ferguson 1981;
Wolffers 1987; Haak 1988; Saradamma et al. 2000; Seeberg 2012).
These drug shops range from high end outlets staffed by pharma-
cists, to small, rural, roadside stalls staffed by someone without for-
mal health qualifications. Unfortunately, it is all too common that
drug selling at these outlets meets the World Health Organization’s
(WHO) criteria for being ‘irrational’. That is, patients do not receive
the appropriate medicines, in doses that meet their individual re-
quirements, for an adequate duration, and at the lowest cost
(Holloway and Van Dijk 2011). To develop appropriate interven-
tions to address this, it is first necessary to understand the nature of
the problem and also the determinants of provider behaviour to re-
flect on how this could best be changed.
Many papers have reported on the inadequacies of pharmacy
practice in LMIC, and some reviews have been conducted (Smith
2009b; Wafula et al. 2012). However, no up to date systematic re-
view is available on performance of pharmacies and drug stores
across Asia’s LMIC. This article aims to address that gap, and in
addition, present the first systematic review of the determinants of
poor practice in these settings, substantially updating and expanding
previous reviews in this area (Goel et al. 1996; Radyowijati and
Haak 2003).
Methods
Scope of review
In many LMIC, there are a wide range of outlets selling medicines to
their local communities. This review is concerned with the full range
of establishments whose primary business is selling medicines.
Papers reporting on pharmacist-run pharmacies (PRPs), non
pharmacist-run pharmacies (NPRPs) and both registered and non-
registered outlets were eligible for inclusion. Despite the legal
requirement to have a trained pharmacist on duty at all times, in
reality, in many countries in Asia, these pharmacies are typically
operated by staff who are not authorized to do so (Wolffers 1987;
Kamat and Nichter 1998; Chuc and Tomson 1999; Seeberg 2012;
Vu et al. 2012). In countries where a shortage of pharmacists exists,
NPRPs are permitted; these are registered outlets but the presence of
a graduate pharmacist is not mandatory. These pharmacies are typ-
ically staffed by personnel with limited medical training and are
sometimes restricted in the repertoire of medicines they are
permitted to sell. Unregistered drug shops sell medicines informally
and are not legally recognized by the health system of the countries
in which they operate (Wafula and Goodman 2010). From this point
onwards, ‘pharmacy’ will be used as an umbrella term to denote all
types of outlets selling medicines.
The first part of the review is concerned with performance of
pharmacies which, in this instance, is conceptualized as behaviour
relating to the sale of medicines, either with or without a prescrip-
tion, or the provision of advice (the importance of the sale of sub-
standard and counterfeit medicines in Asia is also recognized
(Cockburn et al. 2005; Newton et al. 2006; World Health
Organization 2006; Institute of Medicines 2013), but considered be-
yond the scope of this review). The second part of the review con-
cerns the determinants of poor practice, that is, the factors that
contribute to practices that are deemed inappropriate.
Search strategy
A broad search strategy combining MeSH and free text terms was
used to search PubMed, Embase, Econlit, PsychInfo, Web of
Science, Global Health and International Pharmacy Abstracts with
the aim of identifying all studies of pharmacies in LMIC in Asia
(World Bank 2014) (see Table 1).
In addition to the aforementioned databases, the International
Network for Rational Use of Drugs (INRUD) bibliography and the
WHO’s essential medicines and health products information portal
were searched.
The search was restricted to English language studies published
between 1 January 1984 and 29 August 2014. A total of 21 898
papers were initially identified; after removing duplicates, 19 214
titles and abstracts were screened by R.M.; the full-text of 107 re-
cords were obtained; 53 met our inclusion criteria for part 1 of the
review and 38 met the criteria for part 2 (see Figure 1).
Bibliographies of eligible texts were scanned to identify any further
relevant papers.
For part one, papers needed to report on performance relating to
the sale of medicines, either with or without a prescription, or the
provision of advice. This included studies employing both quantita-
tive and qualitative methodologies. In order to collect the most ac-
curate data on pharmacy practice, only studies utilising methods
that collected data at the outlet and relied on a third party observa-
tion of practice were included (studies relying on self-reported prac-
tice were excluded due to the risk of desirability bias and those
collecting data on medicine use through household surveys were
excluded due to the high risk of recall bias). Intervention studies
were included, only where they provided baseline data; this was
thought to reflect standard practice. Where baseline data could not
be disentangled from post-intervention results, studies were
excluded from part one.
Eligible studies for part two reported on both pharmacy per-
formance (applying the same method criteria as for part one) and
possible determinants of that reported performance. Where changes
in practice could be attributed to an intervention strategy, these
intervention studies were included and strategies were viewed as de-
terminants of practice. For example, a training intervention could
shed light on the importance of knowledge as a determinant of prac-
tice. Additionally, qualitative studies which sought to understand
the determinants of practice behaviours were also included. Of the
studies included in part two, 31 of these were a subset of papers
from part one; three papers were intervention studies where the
baseline results were not clear; three papers were intervention
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studies where the baseline results were described by other papers
from the same research study and one paper reported results from a
qualitative study solely focussing on determinants of poor practice.
Data from the included studies were extracted into an excel data-
base under the following headings: date and location of study, which
aspects of performance measured, sampling and study design, data
collection methods, details of intervention, main findings—perform-
ance, main findings—determinants of performance. Key emergent
themes recurring across the data were discussed between the authors
and a narrative synthesis was conducted. See Supplementary Appendix
1 for a full list of included studies and key characteristics.
Results
Part one: performance of pharmacies in LMIC in Asia
This literature review reveals a number of shortcomings in phar-
macy practice. We have organized our findings according to the
stages of an encounter in the pharmacy (Figure 2). Following an
overview of the included studies, we report on six key stages,
namely, the nature of requests from patients, filling of prescriptions,
history taking, referral for medical attention, sale of medicines and
advice giving.
Overview of included studies
This part of the review identified a total of 53 papers from 43 stud-
ies in 14 countries (some studies collected data in more than one
country). Papers coming from the same research project have been
grouped together and the term ‘study’ is used to denote distinct
pieces of research. The most researched countries were India and
Vietnam, with 10 and 9 studies, respectively. Five studies reported
on each of Thailand, Bangladesh and Nepal, three on Indonesia,
two on Sri Lanka and Pakistan and one on The Philippines,
Mongolia, Malaysia, Yemen Arab Republic, Syria and Lao PDR.
Bangladesh and Nepal are low-income countries, Thailand and
Malaysia are higher-middle and all the others are classified as lower-
middle income economies (World Bank 2014).
Studies reported on the full range of pharmacies. PRPs were
included in the majority of research projects. Several papers reported
on outlets legally entitled to operate without a pharmacist, including
type II pharmacies in Thailand, class II and III pharmacies in Lao
Table 1. Search strategy
Target population
(combined by ‘OR’)
Geographic location
(combined by ‘OR’)
Free text terms
Chemist
Drug retailera
Drug shopa
Drug sellera
Drug vendora
Drug storea
Drug dispensing
Drug outleta
Druggist
Medicine retailera
Medicine shopa
Medicine sellera
Medicine vendora
Medicine storea
Medicine
dispensing shopa
Medicine outleta
Medicine dealera
Pharmacies
Pharmacy
Pharmacy servicea
Pharmacista
Pharmaceutical
servicea
MeSH terms
Pharmacy
Pharmacies
Free text terms
Developing
countries
Developing
country
Low-income
country
Low-income
countries
Middle-income
country
Middle-income
countries
Asia
MeSH terms
Developing
countries
Asia
Excluded references from part 1 of review (N= 54)
-no informaon on performance of drug sellers (24)
-methods did not meet inclusion criteria (14) 
- outside geographical area of interest (3)
-intervenon study without clear baseline data (3)
-not empirical research paper (8)
-could not access full text (2)
21,898 records idenﬁed 
through database searching 
Title and abstract screen 
(N= 19,214)
Full text review (N= 107)
Excluded references
 (N= 19,107)
Duplicate references 
(N = 2684)
Included in part 1 of review (N=53)  Included in part 2 of review (N= 38)
Excluded references from part 2 of review (N= 68)
-no informaon on determinants (58)
-methods did not meet inclusion criteria (5) 
-outside geographical area of interest (2)
-not empirical research paper (1)
-could not access full text (2)
Addional records idenﬁed through 
reference lists (N=1)
Figure 1. PRISMA flow diagram.
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PDR, type C pharmacies in Pakistan, drug stores in Indonesia and
drug retailers in Nepal (Kafle et al. 1996; Stenson et al. 2001a; Hadi
et al. 2010; Saengcharoen and Lerkiatbundit 2010;Hussain and
Ibrahim 2011). Only one study from Indonesia reported on unregis-
tered outlets (Hadi et al. 2010).
Researchers employed a range of methods to collect data on
pharmacy practice. Simulated client methodology was used widely
(31 studies) to investigate how a range of requests and conditions
are managed. These included requests for specific prescription only
medicines (POMs), contraceptives and treatment for fever, skin
abrasions, diarrhoea, sexually transmitted infections (STIs), respira-
tory tracts infections (RTIs), tuberculosis, asthma, migraine and an-
aemia. 12 studies used observation in order to record the details of
transactions between pharmacy staff and customers. Exit interviews
with patients were used less frequently (seven studies) to gather in-
formation about medicines purchased and staff behaviour.
1. Nature of client requests
Clients with health concerns visited the pharmacy for three main
reasons: to fill a prescription following a medical consultation; to
purchase a specific medicine(s) or to seek medical advice from the
pharmacy staff. In order to examine staff behaviour and to put cer-
tain practices into perspective, it is useful to understand the fre-
quencies of these different types of scenarios. Eight studies
observed all transactions in sampled pharmacies for a fixed period
of time, ranging from 2 h to 2 weeks per pharmacy. The proportion
of transactions where medicines were purchased without a pre-
scription ranged from around half in studies from Pakistan and
India (Krishnaswamy et al. 1985; Greenhalgh 1987; Kamat and
Nichter 1998; Basak and Sathyanarayana 2010; Hussain and
Ibrahim 2011), to over 80% in a study from Lao PDR (Chuc and
Tomson 1999; Syhakhang et al. 2001) and virtually all transactions
in studies from Vietnam and Malaysia (Chua et al. 2013). Of the
medicines purchased without a prescription, three studies reported
that around one-third were recommended by the pharmacy staff
(Syhakhang et al. 2001; Basak and Sathyanarayana 2010; Chua
et al. 2013). Other studies reported that the vast majority of medi-
cines sold without a prescription were requested by the client, with
pharmacists advising on<5% of these purchases (Krishnaswamy
et al. 1985; Kamat and Nichter 1998; Chuc and Tomson 1999;
Hussain and Ibrahim 2011). Only studies from India reported on
common ways patients requested medicines. These were by name,
on a scrap of paper, or by bringing in an old sample (Greenhalgh
1987; Kamat and Nichter 1998; Saradamma et al. 2000). Studies
from Vietnam, India and Bangladesh reported that at least half of
clients were buying medicines for someone other than themselves,
most commonly a family member (Dua et al. 1994, Duong et al.
1997b; Roy 1997; Kamat and Nichter 1998). One study noted that
domestic servants were commonly sent to purchase medications on
behalf of their employers (Kamat and Nichter 1998).
2. Filling prescriptions
Only a few studies made reference to the handling and process-
ing of prescriptions in the pharmacy. Several poor practices were
reported. Prescriptions were rarely validated by dispensers
(Hussain and Ibrahim 2011), old prescriptions were frequently
honoured (at the extreme, patients were seen to be reusing pre-
scriptions 5 years out of date) (Greenhalgh 1987; Kamat and
Nichter 1998; Basak and Sathyanarayana 2010), and prescrip-
tions were returned to customers after dispensing for reuse in the
future (Puspitasari et al. 2011). Further, doctors’ prescriptions
were not always dispensed as intended. Some studies indicated
that where patients cannot afford to buy all items on a prescrip-
tion, the pharmacists played an important role in advising
Presents a prescripon 
for dispensing 
Paent does not 
have a prescripon 
Paent requests 
medicine 
Paent presents 
symptoms / seeks 
advice of pharmacist 
Refer to physician 
Provides paent with advice and counsels regarding use 
of medicine including: 
• Explanaon of what medicine is for 
• How much to take and when 
• Duraon of treatment 
• Possible side eﬀects 
• Possible interacons with food or other medicines 
• Instances in which medical advice should be sought  
• Any other condion-speciﬁc advice  
Pharmacist sells or dispenses: 
• Appropriate medicine 
• In the appropriate dose 
•  For an appropriate duraon
Query any discrepancies with 
prescribing physician 
Pharmacist checks 
prescripon is valid   
Pharmacist asks history quesons in order to 
establish: 
• Who the medicine is for 
• What is wrong with the paent 
• Whether they have a more serious condion 
that requires medical aenon 
• What acon they have already taken 
• Whether they have any other medical 
condions/ take any other medicaons/ have 
any allergies
1 
1 
1 2 
3 
4 
2
1 
5 
6 
Key 
1 = Nature of client request 
2 = Filling prescripons 
3 = History taking 
4 = Referral for medical aenon 
5 = Sale of medicines 
6 = Advice giving 
Figure 2. Appropriate retail pharmacy practices for patients with and without a prescription.
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patients what they should purchase in light of their financial con-
straints (Greenhalgh 1987; Roy 1997; Kamat and Nichter
1998). Studies did not report a single example of a pharmacist
querying a prescription with the doctor (despite ample descrip-
tion of inappropriate prescribing practices).
3. History taking
In general, history taking in pharmacies was found to be inad-
equate. The majority of these data come from studies where
mystery shoppers presented with symptoms of various condi-
tions, including childhood diarrhoea and STIs. Most questioning
was limited to enquiring about the presence of other related
symptoms and often this was only observed in a subset of the
study pharmacies (Ross-Degnan et al. 1996; Chuc et al. 2001,
Bista et al. 2002; Van Sickle 2006; Saengcharoen and
Lerkiatbundit 2010; Minh et al. 2013). It was rare for pharma-
cists to ask whether the patient suffered from any other condi-
tions or allergies, took any other medication or had tried any
treatments before consulting at the pharmacy (Wachter et al.
1999; Chuc et al. 2001; Van Sickle 2006; Saengcharoen and
Lerkiatbundit 2010; Hussain and Ibrahim 2012). Worryingly, a
common finding was that very few, if any, pharmacists enquired
about danger signs that would indicate a more serious underly-
ing cause and warrant immediate medical attention (Modal and
Lamba 1994; Kafle et al. 1996; Duong et al. 1997a; Wachter
et al. 1999; Saengcharoen and Lerkiatbundit 2010; Rathnakar
et al. 2012). At the extreme end of poor practice, some pharma-
cists were found to ask not a single question (Duong et al.
1997a; Chalker et al. 2000; Rathnakar et al. 2012).
Only three studies measured pharmacists’ responses to direct re-
quests for medications. Questioning was insufficient on who the
medicine was for, what symptoms they were experiencing,
whether they took any other medication or whether they suf-
fered from drug allergies (Ratanajamit and Chongsuvivatwong
2001; Ratanajamit et al. 2002; Larsson et al. 2006; Puspitasari
et al. 2011). Additionally, Kamat and Nichter (1998) describe
the ‘quick presentation of tablets and fast exchange of money’.
4. Referral for medical attention
Some studies used simulated clients to present with symptoms of
conditions that necessitate referral for medical attention; these
included diarrhoea (of 3 day duration) in an 11 month old, cyst-
itis in a man, STIs, asthma and tuberculosis. These conditions re-
quire examination, diagnostic testing or POMs and hence their
management is outside the remit of a pharmacist’s expertise.
Referral practices of pharmacists were found to be unsatisfac-
tory. Tuberculosis was the condition most commonly referred
outside the pharmacy—46% of 138 pharmacies in Vietnam, al-
though only 9% of patients were directed to a designated TB fa-
cility (Vu et al. 2012). For the other conditions, referral
proportions ranged from 7% to 37% (Tomson and Sterky 1986;
Tuladhar et al. 1998; Wachter et al. 1999; Chalker et al. 2000;
Van Sickle 2006; Apisarnthanarak et al. 2008).
5. Sale of medicines
In terms of medicine provision, a number of concerns are raised
by the literature regarding the appropriateness of medicines sold
(with attention to the legal, clinical and physical aspects of their
sale), dosing and duration of treatment.
a. Appropriateness of medicines
i. Legal appropriateness
The sale of POMs without a prescription was a phenom-
enon found to be prevalent in all 14 countries reported
on. A wide range of medicines, which are only legally
permitted to be sold with a prescription, were freely
available without a prescription including: antibiotics,
steroids, antimalarials, narcotic analgesics, psycho-
tropics, anti-epileptics, antihypertensives, anti-
diarrhoels, antihistamines, sedatives, tranquilisers,
hypoglycaemic medicines, anti-tuberculosis agents and
even, on occasion, abortifacients (Krishnaswamy et al.
1985; Tomson and Sterky 1986; Greenhalgh 1987;
Wolffers 1987; Lansang et al. 1990; Dua et al. 1994;
Modal and Lamba 1994; Dineshkumar et al. 1995;
Duong et al. 1997a,b; Roy 1997; Cong et al. 1998;
Kamat and Nichter 1998; Chuc and Tomson 1999;
Wachter et al. 1999; Saradamma et al. 2000; Chuc et al.
2002; Larsson et al. 2006; Mac et al. 2006; Mamun
et al. 2006; Qidwai et al. 2006; Basak and
Sathyanarayana 2010; Hadi et al. 2010; Nakajima et al.
2010; Al-Faham et al. 2011; Puspitasari et al. 2011;
Hussain and Ibrahim 2012; Ngo et al. 2012; Rathnakar
et al. 2012; Seeberg 2012; Vu et al. 2012; Huda et al.
2014; Nga et al. 2014). In Thailand, antibiotics are le-
gally permitted to be sold by class I drug stores but not
in lower class stores. This restriction is reportedly not
observed in practice (Podhipak et al. 1993;
Saengcharoen and Lerkiatbundit 2010). In Indonesia,
antibiotics were found to be freely available through un-
registered roadside kiosks (Hadi et al. 2010).
ii. Clinical appropriateness
The majority of the literature paints a dismal picture of
treatment practices in pharmacies across Asia. More
often than not, medicines that are dispensed are not clin-
ically appropriate for the patients’ needs. Table 2 shows
treatment choices by pharmacy staff for a number of
conditions in response to visits from simulated clients.
At best, studies report that recommended practices are
followed in less than half of encounters (Chuc et al.
2001; Bista et al. 2002). At worst, only a handful, and
in some cases no staff were found to follow best practice
guidelines (Duong et al. 1997a; Van Sickle 2006;
Hussain and Ibrahim 2012; Vu et al. 2012).
These studies also reveal that a number of inappropriate
treatments are given, either in addition to, or, instead of
recommended treatments. Some of the medicines, such
as tonics for anaemia, have no therapeutic value (Kafle
et al. 1996). Others can be harmful, for example the use
of anti-diarrhoels and antitussives in infants and chil-
dren (Tomson and Sterky 1986; Podhipak et al. 1993;
Modal and Lamba 1994; Ross-Degnan et al. 1996;
Duong et al. 1997a; Chuc et al. 2001; Qidwai et al.
2006; Saengcharoen and Lerkiatbundit 2010; Hussain
and Ibrahim 2012; Minh et al. 2013).
Another concern is the overuse of antibiotics. A number
of papers, report that antibiotics were commonly sold
for young babies through to adults for a host of symp-
toms and conditions for which they are not indicated,
including: diarrhoea, asthma, upset stomachs, coughs,
colds, runny noses, influenza and (non-infected) skin
abrasions (Tomson and Sterky 1986; Thamlikitkul
1988; Podhipak et al. 1993; Modal and Lamba 1994;
Ross-Degnan et al. 1996; Duong et al. 1997a,b;
Wachter et al. 1999; Chuc et al. 2001; Chuc et al. 2002;
Qidwai et al. 2006; Van Sickle 2006; Apisarnthanarak
et al. 2008; Saengcharoen and Lerkiatbundit 2010;
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Hussain and Ibrahim 2012; Minh et al. 2013). Further,
even where antibiotics are indicated, inappropriate
choices were made (Tuladhar et al. 1998; Bista et al.
2002). In studies from the Philippines, India, Vietnam
and Lao PDR antibiotics were found to make up be-
tween a fifth and a third of all purchases (Lansang et al.
1990; Dua et al. 1994; Syhakhang et al. 2001; Basak
and Sathyanarayana 2010; Nga et al. 2014).
Tetracycline was reportedly sold to children (for whom
it is contraindicated) in studies from Vietnam, India and
Thailand (Thamlikitkul 1988; Dua et al. 1994; Chuc
and Tomson 1999). Further, the widespread use of
chloramphenicol for minor conditions is a concern due
to the risk of bone marrow suppression (Greenhalgh
1987; Thamlikitkul 1988; Syhakhang et al. 2001).
Vitamins, tonics and nutritional products with dubious
pharmacological value were found to constitute a sig-
nificant proportion of medication costs in studies from
India, Bangladesh, Vietnam and Nepal (Krishnaswamy
et al. 1985; Greenhalgh 1987; Dineshkumar et al. 1995;
Kafle et al. 1996; Duong et al. 1997b; Roy 1997; Chuc
and Tomson 1999; Saradamma et al. 2000; Basak and
Sathyanarayana 2010). They were often seen as an es-
sential accompaniment to antibiotics (Greenhalgh 1987;
Dua et al. 1994; Roy 1997; Saradamma et al. 2000). A
final observation was the popularity of (often irrational)
combination products (Tomson and Sterky 1986;
Greenhalgh 1987; Lansang et al. 1990; Dineshkumar
et al. 1995; Kafle et al. 1996; Chuc and Tomson 1999;
Wachter et al. 1999; Saengcharoen and Lerkiatbundit
2010).
iii. Physical appropriateness
Few studies investigated or commented on the physical
state of the medicines sold to patients. Those that did,
reported that drugs were often sold in loose strips, as
opposed to in their original package; they were rarely
labelled; and different medicines were mixed together
in the same package (Kamat and Nichter 1998; Stenson
et al. 2001a; Van Sickle 2006; Hadi et al. 2010;
Hussain and Ibrahim 2011). As a result, information re-
garding dose, expiry date and active ingredients was
not clear. In six of 28 shops visited in Sri Lanka, tetra-
cycline was not stored in a refrigerator as it should be
(Wolffers 1987).
b. Appropriateness of dose and duration of treatment
Several studies report that medicine dosing was outside of
the therapeutic range for a variety of conditions (both sub-
therapeutic and over dose) (Thamlikitkul 1988; Tuladhar
et al. 1998; Rahman et al. 2000; Bista et al. 2002).
Saradamma et al. (2000) study of antibiotic purchases in
India found that those without a prescription were three
times more likely to purchase an inadequate dose than those
with a prescription (66% vs 40%). The problem of incom-
plete courses of antibiotics was reported in India, Thailand,
Vietnam, Bangladesh, The Philippines and Sri Lanka
(Tomson and Sterky 1986; Greenhalgh 1987; Lansang et al.
1990; Duong et al. 1997a,b; Cong et al. 1998; Chuc and
Tomson 1999; Chalker et al. 2000; Saradamma et al. 2000;
Mamun et al. 2006; Basak and Sathyanarayana 2010). At
the extreme, more than half of antibiotic purchases were for
<2 days (Greenhalgh 1987; Thamlikitkul 1988; Chuc and
Tomson 1999). An interesting finding from Vietnam was
that a higher percentage of incomplete antibiotic courses
were sold for under 1s (Chuc and Tomson 1999).
6. Advice giving
Clients purchasing medicines in the pharmacy were found to re-
ceive very little counselling and advice from pharmacy staff.
Provision of any unsolicited advice ranged widely from 2.5% to
over 70%. Where it was given, however, it was usually limited
to dose and frequency instructions; very few staff mentioned po-
tential side effects, drug or food interactions, or advised to visit
a physician if symptoms continued, worsened or complications
arose (Dua et al. 1994; Modal and Lamba 1994; Kafle et al.
1996; Ross-Degnan et al. 1996; Duong et al. 1997a; Wachter
et al. 1999; Chalker et al. 2000; Chuc et al. 2001; Ratanajamit
and Chongsuvivatwong 2001; Van Sickle 2006; Basak and
Sathyanarayana 2010; Hussain and Ibrahim 2011; Puspitasari
et al. 2011; Saengcharoen and Lerkiatbundit 2013; Huda et al.
2014). Disease and medicine-specific advice and counselling was
also poor, especially for STIs and contraceptive requests
(Tuladhar et al. 1998; Chalker et al. 2000; Rahman et al. 2000;
Ratanajamit and Chongsuvivatwong 2001; Minh et al. 2013).
Advice regarding dietary and fluid intake for clients suffering
from diarrhoea or anaemia was given by a minority of pharmacy
staff (Kafle et al. 1996; Duong et al. 1997a; Wachter et al. 1999;
Saengcharoen and Lerkiatbundit 2010; Minh et al. 2013).
Finally, there was little evidence of signposting to other health
services. This is highlighted by a study from Vietnam where
simulated clients requested an abortifacient. None of the 30
pharmacies visited offered referral materials or contact details
for a specialist service (Ngo et al. 2012).
Part two: determinants of poor pharmacy performance
in LMIC in Asia
Overview of included studies
The literature search yielded 38 relevant papers, from 28 distinct
studies which conducted research in 11 countries: Pakistan (two),
Thailand (five), Nepal (four), India (seven), Bangladesh (three), Lao
PDR (one), Sri Lanka (one), Yemen Arab Republic (one), Vietnam
(six), The Philippines (one) and Indonesia (one). The studies
included in this review are very varied in terms of methodology and
approach but they all shed some light on the determinants of phar-
macy practice in these settings. Ten studies collected data on both
‘actual’ pharmacy practice (e.g. using mystery shopper surveys or
spending time observing transactions) and knowledge and stated
practice (through semi-structured interviews with store staff), with
discordance between the two providing insight into factors affecting
certain poor practices. In uncontrolled analyses, three studies tested
for associations between a number of predictor variables and pro-
vider practices. Four studies conducted regression analyses using as-
pects of practice as the dependent variable and tested a number of
explanatory variables (such as retailer characteristics or attitudes) as
potential predictors of behaviour. Twelve studies evaluated the ef-
fectiveness of an intervention strategy and this provided evidence for
whether or not these were important determinants of practice.
Finally, 10 studies employed qualitative methodology, including in-
depth interviews, participant and non-participant observation and
focus group discussions.
From the literature, information on determinants of poor phar-
macy practice can be distilled into three main categories: knowledge,
profit motives and state intervention. The role of each is discussed.
1. Knowledge
One possible explanation for the poor pharmacy practice
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observed in Asia is simply lack of knowledge. There is wealth of
evidence, however, to suggest that knowing what constitutes
good performance, whilst necessary, is not sufficient to ensure
that this knowledge is employed in practice. A number of studies
report vast discrepancies between knowledge or stated practice
and actual practice; the qualifications of staff or level of training
accomplished appears to make little difference to treatment be-
haviour and finally, educational programmes, whilst improving
practice in the short-term, do not improve practice to a satisfac-
tory level in the long-term. Each of these bodies of evidence will
be examined in turn.
a. Discrepancies between knowledge and practice
Several studies employed different methods in order to elicit
information on both provider knowledge or stated practice
and actual practice. Vast discrepancies were noted between
the two, suggesting that knowledge is not the key determin-
ant of poor practice. Differences between stated practice and
actual practice were observed for the sale of medicines, refer-
ral for medical advice, history taking and advice giving. For
example, in hypothetical scenarios, 32% of pharmacists said
they would sell any drugs for a man with urethral discharge
and pain on urinating (the recommended management
would be referral to a physician) (Chalker et al. 2000), 20%
antibiotics for a child with a viral upper respiratory tract in-
fection (Chuc et al. 2001), 40% corticosteroids and 0% anti-
epileptic medicines without a prescription (Larsson et al.
2006; Mac et al. 2006). In mystery shopper surveys, how-
ever, these actions were carried out by 85%, 83%, 98% and
21%, respectively. Adherence to recommended treatment
practices was also found to be poorer in practice. Compared
to the stated medication treatments for childhood diarrhoea,
fewer pharmacy staff sold oral rehydration salts (ORS) and
more sold inappropriate antibiotics and anti-diarrhoels
(Ross-Degnan et al. 1996; Saengcharoen and Lerkiatbundit
2010; Minh et al. 2013). Similar patterns were observed in
the management of other conditions, such as STIs (Khan
et al. 2006). One study reported that despite 81% of
pharmacists knowing that antibiotics were not effective in
short courses, 48% of courses dispensed were for<5 days.
Stated referral practices of patients presenting with condi-
tions that need to be treated by a doctor were three to four
times higher than in reality (Chalker et al. 2000; Khan et al.
2006). Finally, history taking and advice giving in question-
naires was found to be superior to the service simulated cli-
ents experienced (Ratanajamit and Chongsuvivatwong
2001; Khan et al. 2006).
b. Qualifications/training and experience
Studies from Thailand and Nepal, using simulated shoppers
to investigate the management of childhood diarrhoea, preg-
nancy-related anaemia and requests for contraceptives, re-
vealed that staff with higher levels of training or
qualifications asked more questions and gave better advice
but little differences were observed in terms of appropriate
medication dispensing (Kafle et al. 1996; Ratanajamit and
Chongsuvivatwong 2001; Saengcharoen and Lerkiatbundit
2010). Other studies found no association between qualifica-
tions of pharmacy personnel and the quality of history tak-
ing and counselling (Hussain and Ibrahim 2011;
Saengcharoen and Lerkiatbundit 2013). Despite, recording
no differences in actual practice, one of these papers re-
ported that, in interviews designed to measure their
T
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.
C
o
n
ti
n
u
e
d
C
o
n
d
it
io
n
C
o
u
n
tr
ie
s,
n
u
m
b
er
o
f
d
is
ti
n
ct
st
u
d
ie
s
a
n
d
re
fe
re
n
ce
s
R
ec
o
m
m
en
d
ed
tr
ea
tm
en
t
S
a
m
p
le
p
er
ce
n
t
g
iv
in
g
a
p
p
ro
p
ri
a
te
tr
ea
tm
en
t
D
et
a
il
s
o
f
in
a
p
p
ro
p
ri
a
te
tr
ea
tm
en
t
(
K
a
fl
e
et
a
l.
1
9
9
6
,
2
0
1
3
)
F
er
ro
u
s
su
lp
h
a
te
5
8
–
7
1
%
g
a
v
e
a
n
ir
o
n
p
re
p
a
ra
ti
o
n
o
f
so
m
e
k
in
d
(w
h
il
st
n
o
t
th
e
re
co
m
-
m
en
d
ed
p
ro
d
u
ct
,
st
il
l
cl
in
ic
a
ll
y
ef
fe
ct
-
iv
e,
b
u
t
m
o
re
co
st
ly
)
1
2
%
g
a
v
e
a
v
it
a
m
in
o
r
m
in
er
a
l
p
ro
d
-
u
ct
th
a
t
w
a
s
n
o
t
th
er
a
p
eu
ti
c
fo
r
p
re
g
-
n
a
n
cy
-r
el
a
te
d
a
n
a
em
ia
9
%
d
is
p
en
se
d
to
n
ic
s
th
a
t
w
er
e
n
o
t
th
er
a
p
eu
ti
c
M
ig
ra
in
e
T
h
a
il
a
n
d
1
st
u
d
y
(
S
a
en
g
ch
a
ro
en
a
n
d
L
er
k
ia
tb
u
n
d
it
2
0
1
3
)
In
te
rn
a
ti
o
n
a
l
re
co
m
m
en
d
a
ti
o
n
s:
N
S
A
ID
fo
r
m
il
d
m
ig
ra
in
e
E
rg
o
ta
m
in
e
fo
r
m
o
d
er
a
te
m
ig
ra
in
e
3
3
%
d
is
p
en
se
d
a
p
p
ro
p
ri
a
te
ly
fo
r
m
il
d
m
ig
ra
in
e
5
4
%
d
is
p
en
se
d
a
p
p
ro
p
ri
a
te
m
ed
ic
in
e
fo
r
m
o
d
er
a
te
a
tt
a
ck
I
n
a
p
p
ro
p
ri
a
te
p
ro
p
h
y
la
ct
ic
m
ed
ic
in
es
su
ch
a
s
p
ro
p
ra
n
o
lo
l
a
n
d
a
te
n
o
lo
l
w
er
e
re
co
m
m
en
d
ed
b
y
2
8
%
a
n
d
1
8
%
fo
r
m
o
d
er
a
te
a
n
d
m
il
d
a
tt
a
ck
s
re
sp
ec
ti
v
el
y
a
D
et
a
il
s
o
f
sp
ec
ifi
c
a
n
ti
b
io
ti
cs
u
n
sp
ec
ifi
ed
b
y
st
u
d
y
.
8 Health Policy and Planning, 2016, Vol. 0, No. 0
 at London School of H
ygiene &
 Tropical M
edicine on A
pril 27, 2016
http://heapol.oxfordjournals.org/
D
ow
nloaded from
 
knowledge, pharmacists achieved significantly higher scores
compared to non-pharmacists in the areas of history taking
and advice provision (Saengcharoen and Lerkiatbundit
2013). Experience was shown not to be a predictor of appro-
priate dispensing in the two studies which collected data on
this variable (Apisarnthanarak et al. 2008; Saengcharoen
and Lerkiatbundit 2010).
c. Impact of education programmes
Nine studies report the findings of educational interventions.
All of these studies employed simulated client methodology
to assess the impact of training; only four assessed perform-
ance by comparing outcomes to a control group. On the
whole, training was found to improve the treatment behav-
iour of various conditions, including diarrhoea and STIs, as
well as provision of contraceptives (Ross-Degnan et al.
1996; Kafle 1998; Tuladhar et al. 1998; Ratanajamit et al.
2002; Qidwai et al. 2006; Kafle et al. 2013; Minh et al.
2013; Pham et al. 2013). Despite the improvements noted,
inadequacies in treatment practice remained. For example,
in Indonesia, 46% of staff continued to sell anti-diarrhoels
for children with diarrhoea (Ross-Degnan et al. 1996); and
in Nepal, 55% of drug sellers continued to prescribe an STI
treatment regimen that was inconsistent with national guide-
lines (Tuladhar et al. 1998). Further, most of the study fol-
low-up times were<6 months. One study with follow-up at
7–9 months noted the waning of effect (Tuladhar et al.
1998), and another at 32 months reported no sustained im-
provements in the use of ORS, anti-diarrhoels or antibiotics
for the treatment of diarrhoea, despite promising results at 6
months post intervention (Minh et al. 2013; Pham et al.
2013). In Nepal, small group training led to significant
improvements in a number of aspects of management of
childhood diarrhoea, acute respiratory infection and an-
aemia in pregnancy at 2 months but most of these effects
were not sustained at the 5-month follow-up (Kafle 1998).
One study did not report baseline data but the post-training
results concerning the management of STIs were very poor
(Khan et al. 2006). Another showed no significant impact of
training on ORS use for the treatment of diarrhoea or dysen-
tery, but it did show improvements in antibiotic dispensing,
only for drug sellers, however, not for pharmacists
(Podhipak et al. 1993).
2. Profit motives
Pharmacies are retail businesses operating within a competitive
marketplace. Several papers described the proliferation of medi-
cine outlets over recent decades, especially in countries that
underwent economic liberalisation. For example, in Vietnam fol-
lowing the privatization of drug provision in 1986, the number
of private pharmacies increased from none to>6000 by 1996
(Chuc et al. 2002). These papers also noted the intensified com-
petition that resulted (Kamat and Nichter 1998; Chuc and
Tomson 1999; Stenson et al. 2001b; Chuc et al. 2002). An illus-
tration of the nature of competition comes from Mumbai, India,
where pharmacies hire agents to persuade patients leaving hos-
pitals to patronise their pharmacy (Kamat and Nichter 1998).
Qualitative work confirms that pharmacies report feeling intense
competition and staff seek to maximize profit in order to survive
in the market (Dua et al. 1994; Kamat and Nichter 1998; Chuc
and Tomson 1999; Kotwani et al. 2012; Seeberg 2012).
Essentially there are three ways to maximize profits: maximizing
the number of customers, maximizing the revenue from each in-
dividual customer and minimizing costs. From the literature, we
identified a number of strategies employed by pharmacy staff to
achieve these goals, each of which can also be linked to poor
practice.
a. Complying with customer demands
The literature reveals that pharmacy staff are very responsive
to patients wishes, adhering to a ‘customer is king’ mentality.
In the name of maintaining clients, inducing loyalty and pre-
venting customers from fulfilling their requests elsewhere,
pharmacies resort to a number of poor practices. These in-
clude honouring improper prescriptions, such as those that
are out of date, and selling POMs without a prescription
(Dua et al. 1994; Larsson et al. 2006; Kotwani et al. 2012;
Nga et al. 2014). Further, incomplete courses of antibiotics
are frequently sold. Patients request these short courses due
to economic constraints, a desire to test the therapeutic effi-
cacy and presence of side-effects before purchasing larger
quantities, and a belief that a full course is unnecessary
(Lansang et al. 1990; Dua et al. 1994; Dineshkumar et al.
1995; Roy 1997;Duong et al. 1997b; Kamat and Nichter
1998; Mamun et al. 2006).
b. Selling medicines based on perceived efficacy
Several studies reported that pharmacy staff chose medicines
based on their ability to produce a rapid recovery or tempor-
ary relief from symptoms, even where they were not appro-
priate (Kafle et al. 1996; Van Sickle 2006; Saengcharoen and
Lerkiatbundit 2010,). For example, anti-diarrhoels for the
treatment of childhood diarrhoea (Saengcharoen and
Lerkiatbundit 2010) or airway relaxers for the respiratory
symptoms associated with asthma (Van Sickle 2006). In add-
ition, they sold medicines in which clients were believed to
have great confidence, again, even if such medicines were not
necessary. Examples include tonics as an accompaniment to
antibiotics, and complex vitamin preparations (Dua et al.
1994; Kafle et al. 1996).
c. Mimicking doctors
Four studies reported that it was common practice for medi-
cine retailers to study the prescriptions bought in by patients
and then model their own prescribing on the practices of
local doctors (Greenhalgh 1987; Kafle et al. 1996; Ross-
Degnan et al. 1996; Seeberg 2012). This may simply be a
way to improve knowledge. It could, however, be inferred
that it is a strategy used by pharmacies in order to be viewed
as more legitimate by customers.
d. Maintaining good relationships with doctors
When presented with clinically inappropriate prescriptions,
pharmacies in Asia tended to dispense them rather than query
their appropriateness with the doctor. Pharmacists interviewed
in Kotwani et al’s qualitative study of irrational antibiotic use in
Delhi described their low status in the medical hierarchy and
how doctors would rebuke them for challenging their authority
(Kotwani et al. 2012). Other research, also in India, has identi-
fied symbiotic relationships between doctors and chemist shops,
and doctors have been observed to mention names of shops
where patients should fill their prescriptions (Kamat and
Nichter 1998; Seeberg 2012). Further, at the request of medical
representatives, doctors reportedly prescribe more of particular
products when local pharmacies experience an overstock
(Kamat and Nichter 1998). It is understandable, in such a con-
text, that pharmacists do not query more prescriptions for fear
of aggravating local physicians.
e. Medicine sales
Two explicit strategies for maximizing profits from medicine
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sales were identified from the literature; selling large volumes
of low priced drugs and recommending medicines that yield
the greatest profit (Ross-Degnan et al. 1996; Chuc and
Tomson 1999; Saengcharoen and Lerkiatbundit 2010).
Antibiotics are singled out as high profit generators (Chuc
and Tomson 1999; Chuc et al. 2001; Saengcharoen and
Lerkiatbundit 2010; Nga et al. 2014); this may partly ex-
plain their rampant overuse.
f. Medicine purchasing
The pharmaceutical industry employs aggressive marketing
techniques which involve promotional offers to pharmacies.
This includes bonus schemes whereby the purchase of x
amount of a product includes y amount for free (Kamat and
Nichter 1998). Retailers are then incentivized to sell more of
this product, regardless of its appropriateness, because it will
yield high profits. The following quote from Kamat and
Nichter’s (1998) ethnographic study of pharmacies and
pharmaceutical-related behaviour in India gives an insight
into such practice (the product mentioned, Superaction, an
OTC product for cough, cold, fever and pain, is sold on a
buy 12 strips get 7 free basis):
I make a profit of anything between 75% and 100% on
“Superaction.” During the past 2 week, I sold two boxes (20
strips) of this item for which I got a pocket calculator worth
80 rupees from the company. I make a lot of profit on this
product, but I have to counter-push it because local doctors
do not prescribe it. I do not recommend this product to every
customer who asks for medicines for headache or body pain
but mostly to angutachapwallas (illiterates) who come and
ask me to give some medicine for cold and pain (Kamat and
Nichter 1998).
Dineshkumar et al. (1995) comment on the aggressive mar-
keting of vitamins which are used extensively in India.
Seeberg describes how chemists in Orissa purchase substand-
ard medicines from local production facilities at a 50% dis-
count and then sell them on to customers thus making
additional profit (Seeberg 2012).
It is important to note that there are examples in the litera-
ture which illustrate that medicine retailers are only prepared
to go so far in risking the health of their patients in the name
of making a quick profit. Pharmacists described how it was
not suitable to use substandard medicines for patients who
had undergone surgery or faced life-threatening conditions
(Seeberg 2012). Additionally, when patients sought pharma-
cists’ advice in the event of not being able to afford all medi-
cines on a prescription, they were found to recommend the
medicines which ‘cure’ over those with the highest profit
(Kamat and Nichter 1998).
3. State intervention
A few studies in this review provide information on the impact
of government intervention on pharmacy performance.
a. Regulation
Two intervention studies reported on the effect of regula-
tion on service quality. An intervention in Lao PDR involv-
ing inspection visits, punishments in the case of gross
violations of the sanctions, up-to-date supply of regulatory
documents, and reinforcement of the rules found marked
improvements in the availability of essential medicines,
order in the pharmacy and provision of information;
and less mixing of different drugs in the same package
(Stenson et al. 2001b). The regulatory component of a
multi-component (sequentially applied), intervention on
dispensing practices in Bangkok (Thailand) was the only
component of the intervention that resulted in a significant
change in practice (reduced dispensing of a prescription-
only steroid compared to the control group). This interven-
tion focussed on the illegality of the act and the threat of
punishment should such practice be observed. The same
study reported that in Hanoi (Vietnam), where less focus
was placed on sanctions, the regulatory component of the
intervention did not lead to an immediate change in behav-
iour (Chalker et al. 2005).
b. National Public Health Programmes
A study from Vietnam investigating the management of tu-
berculosis patients in the pharmacy found, in a multivariate
analysis, that staff who were aware both of the National
Tuberculosis Programme (NTP) and that tuberculosis medi-
cines were provided for free were 5.8 times more likely to
refer a suspect directly to a tuberculosis facility than those
who were not (Vu et al. 2012). Another study concerned
with management of childhood diarrhoea investigated prac-
tice in three countries: Bangladesh, Sri Lanka and Yemen
Arab Republic. The authors reported that ORS was more
commonly dispensed in Bangladesh and they noted the pres-
ence of a national ORS programme as one potential explan-
ation (Tomson and Sterky 1986).
Discussion
Combined, the reviews identified 60 papers reporting on pharmacy
practice and/or determinants of poor practice in 15 LMICs in Asia.
The majority of studies were from lower middle-income countries.
Asides from studies from Mongolia, Yemen Arab Republic and
Syria, all other studies focussed on countries from South and South-
East Asia. As such, the results tell us little about pharmacy practice
in North Asia, Central Asia, West Asia or the Middle East. Most re-
search was carried out on PRPs, with less on NPRPs and research on
unregistered shops was found to be practically non-existent.
Given the diversity of studies found in the search, quality
appraisal proved to be a particular challenge. Relevant papers
included a range of designs including randomised controlled trials,
cross-sectional descriptive surveys and ethnographies. The lack of
clear criteria by which qualitative studies should be judged in the
systematic review process has been raised by others but remains an
unresolved issue (Dixon-Woods et al. 2006). In light of this, it was
decided to include all papers which met the inclusion criteria provid-
ing the methodology employed was clear. Data on both methods
and study design were extracted and any potential threats to validity
were recorded. The main concerns noted were small sample sizes
and non-random sampling (quantitative papers). The findings of
poorer quality studies, however, were found to be consistent with
more rigorously designed ones. In interpreting the findings, care has
been taken to emphasise those which were found in a number of
studies and across countries.
In terms of pharmacy performance, the findings across countries
and over time are remarkably consistent. Pharmacy practice in Asia
appears to have changed little in the past 30 years. The same prob-
lems documented by studies in the 1980s are true of practice in re-
cent times (Tomson and Sterky 1986; Greenhalgh 1987; Hussain
and Ibrahim 2012; Seeberg 2012; Vu et al. 2012; Chua et al. 2013;
Minh et al. 2013; Saengcharoen and Lerkiatbundit 2013). Practice
appears to fall short throughout the pharmacy encounter. The key
inadequacies documented throughout the literature are: insufficient
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history taking prior to the sale of medicines; a lack of referral of pa-
tients whose management is outside of the remit of a pharmacist’s
expertise; the illegal sale of a wide range of POMs without a pre-
scription; the sale of medicines that are either clinically inappropri-
ate and/or in doses that are outside of the therapeutic range; the sale
of incomplete courses of antibiotics; and finally, limited provision of
information and counselling to accompany the sale of medicines.
Similar challenges have also been documented in Sub-Saharan
Africa (Wafula et al. 2012)
Staff working in pharmacies can be seen as the gatekeepers of
medicines. They stand at the interface between producers and con-
sumers of medicines and their role is to ensure that they are used
safely, effectively and rationally (Anderson 2002). When used cor-
rectly, medicines can save lives and improve people’s health; irra-
tional use, however, can have harmful consequences. A number of
conditions were found to be treated inadequately in the pharmacy,
including diarrhoea, asthma, anaemia, tuberculosis, STIs, RTIs and
migraine. This mistreatment can lead to unnecessary morbidity and
mortality. For example, many studies reporting on the management
of childhood diarrhoea found under-provision of ORS and over-
provision of anti-diarrhoeals and antibiotics. The use of anti-
diarrhoels in infants has been shown to be harmful (Minton and
Smith 1987; Li et al. 2007) and it is estimated that correct treatment
with ORS may prevent 93% of diarrhoeal deaths in children under
5 (Munos et al. 2010). In South Asia, diarrhoea is thought to ac-
count for 23% of all deaths in children under 5 (Morris et al. 2003).
Overuse of antibiotics is a particular concern for public health,
as misuse of antibiotics over recent decades has led to the selection
and spread of resistant bacteria. As a result, antibacterial drugs have
become less effective and in some cases, ineffective. Earlier this year,
a WHO global report on the surveillance of antibiotic resistance
described the problem as a ‘global health security emergency’
(World Health Organization 2014).
A further concern is the economic impact of spending on house-
holds, especially the poor. Customers typically pay for the medicines
purchased at pharmacies out of their own pocket and where these
medicines are inappropriate or ineffective this represents a waste of
scarce resources. Work in Asia has shown that, in many countries, a
large proportion of out of pocket payments is spent on medicines.
For example, in Bangladesh, Vietnam and India, this share is 70%
(Van Doorslaer et al. 2007). Further, in these countries, out of
pocket payments for healthcare can be ‘catastrophic’, accounting
for>25% of household resources (excluding food costs) in at least
10% of all households (ibid).
Turning to the determinants of the poor practice documented
above, the picture is less clear. Despite the importance of pharmacies
and the potential benefit for public health if practice were to im-
prove, efforts to understand and address the problem have been sur-
prisingly few. Historically, the small number of attempts to improve
pharmacy practice in Asia has focussed on training interventions.
This review finds that whilst a necessary condition, adequate know-
ledge alone is not sufficient to ensure appropriate management of
patients presenting at the pharmacy. Profit motives and the regula-
tory environment appear to play a role but the research evidence is
relatively sparse. In terms of the methods used to unpick the under-
lying determinants of pharmacy behaviours, we found that in-depth
qualitative studies, particularly those employing an ethnographic ap-
proach, provided the richest data (Kamat and Nichter 1998; Seeberg
2012). Unfortunately, studies using this approach are rare.
Whilst a number of studies have been published in the two dec-
ades since Goel et al. (1996) first reviewed this literature, there is lit-
tle new insight into the problem of poor pharmacy practice. They
noted that regulatory factors had been ‘strikingly neglected by re-
searchers’ and called for new research on the ‘impact of professional
ownership on professional freedom’. Researchers have, on the
whole, continued to neglect these areas. The pursuit of regulatory
enforcement is, however, not a straightforward solution and we
must be aware that enforcing laws surrounding the sale of POMs
would potentially deny many people access to essential medicines,
thus violating a basic principle of public health.
Based on the intervention literature both within and outside
Asia, the menu of evidence-based options for professional bodies
and policy-makers to inform improvement and development of
pharmacy services is limited (Smith 2009a). Arguably, some cadre
of trained pharmacy workers should be in place in order to provide
a basis for improvement, yet in many settings human resource limi-
tations undermine the ability to provide this (Smith 2009b). Asides
from training and regulation, other schemes that have been imple-
mented include peer review, accreditation (such as the Accredited
Drug Dispensing Outlets scheme in Tanzania) and social franchising
(Chalker et al. 2005; Wafula and Goodman 2010). However, the
evidence on the impact and sustainability of these strategies remains
quite limited, highlighting this area as an important priority for fu-
ture research (Center for Pharmaceutical Management 2008;
Wafula and Goodman 2010; Valimb et al. 2014).
It is worth noting that new organisational arrangements of phar-
macy retail in the form of chains and franchises are a growing phe-
nomenon in LMIC both in Asia and elsewhere (Lowe and Montagu
2009; IMS Consulting Group 2014). This phenomenon raises im-
portant questions about the impact of professional and organised
ownership on pharmacy practice. Further, theoretical literature sug-
gests that the organisational structure of the pharmacy firm may af-
fect both the regulatory environment and financial incentives, as
well as provider knowledge (Klein 1980; Blair and Kaserman 1994;
Frant 1996; Bloom et al. 2008).
Cross and Macgregor (2010) have criticised the current debates
around ‘informal providers’ (including drug sellers) which, they
argue, are myopically focused on ‘small time economic actors’ rather
than giving attention higher up in the pharmaceutical supply chain
(Cross and Macgregor 2010). This focus indeed leads to a distrac-
tion away from the pharmaceutical industry, which, thus far, has
largely remained absent from discussions of inappropriate medicines
use. A few papers in this review touch on the pressures that pro-
viders face from industry but this does not come out strongly.
Whilst it is necessary to study frontline behaviours, research up-
stream is also a necessity.
Conclusion
Pharmacies are an important component of the health system in
LMIC in Asia. In many areas they act as ‘de facto primary health-
care providers’ (Seeberg et al. 2014). The service they provide, how-
ever, does not live up to international expectations of pharmacy
practice. The consequences of poor practice can have harmful effects
for public health and, as such, these outlets warrant more attention
from public health researchers. The nature of the problem with
pharmacies in Asia is well established, although more attention
could be paid to NPRPs pharmacies and unregistered drug shops.
Future research efforts should focus their attention on investigating
the underlying causes and ways to improve the current situation.
The little evidence that is available suggests that intervention strat-
egies should take into account the regulatory environment and profit
incentives faced by pharmacy personnel and not continue to focus
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solely on improving knowledge. If efforts are focussed accordingly it
is hoped that the realities of the past 30 years of poor pharmacy
practice in Asia will not continue for the next 30.
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